image
Benitec Biopharma Inc. BNTC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.68
2.69 %
$ 212 M
Market Cap
-1.94
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2024-06-30 188.00% -11.19% -17.87%
Annual Report FY 10-K 2023-06-30 2.74% -5.39% -6.87%
Annual Report FY 10-K 2022-06-30 23.73% -34.69% -31.32%
Annual Report FY 10-K 2021-06-30 -39.18% -66.02% -64.18%
Annual Report FY 10-K 2020-06-30 -99.14% -289.52% -413.44%
Annual Report FY 10-K 2019-06-30 2384.77% 133.53% 123.42%
Annual Report FY 10-K 2018-06-30 1.14% -95.56% 46.29%
Annual Report FY 10-K 2017-06-30 29.96% 76.37% 36.21%
Annual Report FY 10-K 2016-06-30 -58.21% -109.62% -87.28%
Annual Report FY 10-K 2015-06-30 -18.53% 18.53% 7.44%
Annual Report FY 10-K 2014-06-30 86.49% -68.68% -76.51%
Annual Report FY 10-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2024-09-30 0.00% 15.03% 1.41%
Quarterly Report Q4 8-K 2024-06-30 0.00% -1.27% -21.93%
Quarterly Report Q3 8-K 2024-03-31 -88.89% 4.06% 4.54%
Quarterly Report Q2 8-K 2023-12-31 0.00% -30.43% -23.48%
Quarterly Report Q1 8-K 2023-09-30 0.00% -6.21% -28.25%
Quarterly Report Q4 8-K 2023-06-30 0.00% 8.01% 3.97%
Quarterly Report Q3 8-K 2023-03-31 12.50% -44.34% -25.46%
Quarterly Report Q2 8-K 2022-12-31 -44.00% -8.11% -16.03%
Quarterly Report Q1 8-K 2022-09-30 0.00% -11.12% 5.02%
Quarterly Report Q4 8-K 2022-06-30 0.00% -26.58% -22.91%
Quarterly Report Q3 8-K 2022-03-31 4700.00% 20.95% 8.78%
Quarterly Report Q2 8-K 2021-12-31 2400.00% -48.25% -48.36%
Quarterly Report Q1 8-K 2021-09-30 0.00% -85.61% -79.26%
Quarterly Report Q4 8-K 2021-06-30 105.00% -36.39% -33.53%
Quarterly Report Q3 8-K 2021-03-31 -96.43% -85.97% -79.68%
Quarterly Report Q2 8-K 2020-12-31 -98.70% -55.60% -54.38%
Quarterly Report Q1 8-K 2020-09-30 66.67% -136.97% -130.70%
Quarterly Report Q4 8-K 2020-06-30 -6.22% -99.80% -91.19%
Quarterly Report Q3 8-K 2020-03-31 -95.00% -23.36% -21.88%
Quarterly Report Q2 8-K 2019-12-31 -98.63% -80.78% -71.52%
Quarterly Report Q1 8-K 2019-09-30 -99.40% -35.01% -39.58%
Quarterly Report Q4 8-K 2019-06-30 2021.69% 24.65% 28.06%
Quarterly Report Q3 8-K 2019-03-31 469.57% 17.69% 16.31%
Quarterly Report Q2 8-K 2018-12-31 2363.12% 213.79% 175.75%
Quarterly Report Q1 8-K 2018-09-30 5481.82% 245.13% 182.90%
Quarterly Report Q4 8-K 2018-06-30 -62.48% 1.92% 43.33%
Quarterly Report Q3 8-K 2018-03-31 -46.49% -722.87% 40.91%
Quarterly Report Q2 8-K 2017-12-31 125.37% 15.76% 3.18%
Quarterly Report Q1 8-K 2017-09-30 16.77% -398.85% 24.27%
Quarterly Report Q4 8-K 2017-06-30 56.31% 53.94% 19.02%
Quarterly Report Q3 8-K 2017-03-31 204.26% 89.88% 18.84%
Quarterly Report Q2 8-K 2016-12-31 32.66% 51.96% 46.35%
Quarterly Report Q1 8-K 2016-09-30 -46.49% 109.30% 45.25%
Quarterly Report Q4 8-K 2016-06-30 -84.45% -7.38% -9.64%
Quarterly Report Q3 8-K 2016-03-31 331.24% -265.61% -16.05%
Quarterly Report Q2 8-K 2015-12-31 -70.84% -172.11% -237.16%
Quarterly Report Q1 8-K 2015-09-30 -43.40% -175.62% -260.28%
Quarterly Report Q4 8-K 2015-06-30 -38.72% -132.20% -149.64%
Quarterly Report Q3 8-K 2015-03-31 -4.90% 60.05% -126.29%
Quarterly Report Q2 8-K 2014-12-31 161.11% -37.08% -29.67%
Quarterly Report Q1 8-K 2014-09-30 167.07% -40.21% -32.63%
Quarterly Report Q4 8-K 2014-06-30 37.18% -4766.95% -165.26%
Quarterly Report Q3 8-K 2014-03-31 18.62% -4121.80% -129.37%
Quarterly Report Q2 8-K 2013-12-31 -66.65% 15.54% -66.83%
Quarterly Report Q1 8-K 2013-09-30 -65.15% 11.73% -74.36%
Quarterly Report Q4 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2012-09-30 0.00% 0.00% 0.00%